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Abstract
In cardiac muscle, signaling through cAMP governs many fundamental cellular functions, 
including contractility, relaxation and automatism. cAMP cascade leads to the activation of the 
classic protein kinase A but also to the stimulation of the recently discovered exchange protein 
directly activated by cAMP (Epac). The role of Epac in the regulation of intracellular Ca2+ 
homeostasis and contractility in cardiac myocytes is still matter of debate. In this study we showed 
that the selective Epac activator, 8-(4-chloro-phenylthio)-2′-O-methyladenosine-3′, 5′-cyclic 
monophosphate (8-CPT), produced a positive inotropic effect when adult rat cardiac myocytes 
were stabilized at low [Ca2+]o (0.5 mM), no changes at 1 mM [Ca2+]o and a negative inotropic 
effect when [Ca2+]o was increased to 1.8 mM. These effects were associated to parallel variations 
in sarcoplasmic reticulum (SR) Ca2+ content. At all [Ca2+]o studied, 8-CPT induced an increase in 
Ca2+ spark frequency and enhanced CaMKII autophosphorylation and the CaMKII-dependent 
phosphorylation of SR proteins: phospholamban (PLN, at Thr17 site) and ryanodine receptor 
(RyR2, at Ser2814 site). We used transgenic mice lacking PLN CaMKII phosphorylation site 
(PLN-DM) and knock-in mice with an inactivated CaMKII site S2814 on RyR2 (RyR2-S2814A) 
to investigate the involvement of these processes in the effects of Epac stimulation. In PLN-DM 
mice, 8-CPT failed to induce the positive inotropic effect at low [Ca2+]o and RyR2-S2814A mice 
showed no propensity to arrhythmic events when compared to wild type mice myocytes. We 
conclude that stimulation of Epac proteins could have either beneficial or deleterious effects 
depending on the steady-state Ca2+ levels at which the myocyte is functioning, favoring the 
prevailing mechanism of SR Ca2+ handling (uptake vs. leak) in the different situations.
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INTRODUCTION
cAMP is a universal second messenger that plays a central role in the regulation of cardiac 
contractility. In the last years, it has become recognized that along with the cAMP effector 
protein kinase A (PKA), the exchange protein directly activated by cAMP (Epac) 
participates in many cAMP-controlled processes of heart function. Among them, activation 
of Epac has been involved in the regulation of Ca2+ homeostasis in cardiac myocytes, Ca2+ 
myofilament sensitivity, gap junction formation, arrhythmogenesis, apoptosis, autophagy, 
hypertrophy, vascular integrity and cardiac fibrosis (1, 2).
The Epac protein family is composed of Epac1 and Epac2, which act as guanine-nucleotide 
exchange factors for the small G proteins Rap1 and Rap2, in a PKA-independent manner. In 
mouse and human hearts, Epac1 is the most abundant isoform (3, 4) and its expression is 
developmentally regulated, with the Epac1/Epac2 mRNA ratio decreasing in adulthood (4).
Several studies in isolated cardiac myocytes have shown that stimulation of Epac by the 
selective activator, 8-(4-chloro-phenylthio)-2′-O-methyladenosine-3′, 5′-cyclic 
monophosphate (8-CPT), increased the activity of the Ca2+ and calmodulin-dependent 
protein kinase II (CaMKII) and the phosphorylation of two sarcoplasmic reticulum (SR) 
targets, the Ca2+ release channel (RyR2) and the Ca2+ pump (SERCA2a) regulator, 
phospholamban (PLN) (3, 5–8). Moreover, at the level of the myofibrils, 8-CPT enhanced 
the CaMKII-dependent phosphorylation of myosin-binding protein C (MyBPC) and 
troponin I (TnI) (9). Even though CaMKII appears as a clear downstream signal of Epac, the 
pathway that leads to its activation is still debated. The Epac-mediated effects have been 
shown to require the presence of ε isoform of phospholipase C (PLCε) (5, 7) and the 
resultant increase in cytosolic Ca2+ triggered by IP3 as well as the diacylglycerol-activated 
PKCε, have been implicated in the stimulation of CaMKII under different experimental 
conditions (5, 7, 10). Additionally, it has recently been reported a nitric oxide synthase and 
phosphoinositide 3-kinase dependent activation of CaMKII during Epac stimulation (8).
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The role of Epac in the regulation of intracellular Ca2+ homeostasis and contractility is still 
matter of debate. In rat adult cardiomyocytes, acute Epac stimulation decreased the 
amplitude of Ca2+ transients (6, 9, 10) with either no changes (6) or increments (9) in cell 
shortening, suggesting an enhancement of myofilament Ca2+ sensitivity. This was confirmed 
in the latter study and supported by the finding of the increased CaMKII-phosphorylation of 
MyBPC and TnI (9). The diminished Ca2+ transient was paralleled by a decrease in the 
amount of Ca2+ stored in the SR, attributed to the increased SR Ca2+ leak induced by the 
CaMKII-dependent phosphorylation of RyR2 (6). In contrast to rat myocytes, an increase (5, 
7) or no change in Ca2+ transient (11) were detected in mice myocytes after acute 
stimulation of Epac. As in the rat, 8-CPT induced an enhancement of the CaMKII-dependent 
phosphorylation of RyR2 and PLN (7). Furthermore, the Epac-specific agonist caused 
spontaneous triggered activity in intact perfused murine hearts, associated with increased 
incidence of spontaneous Ca2+ transients and propensity to the generation of Ca2+ waves at 
the myocyte level (11). Such arrhythmogenic features were also observed in rat myocytes 
but after sustained Epac activation (12). In this case, rat myocytes showed an increase in 
Ca2+ transient, cell shortening and SR Ca2+ content, favored by enhanced Ca2+ influx 
through the L-type Ca2+ channels. The development of KO mice did not help to clarify the 
specific involvement of Epac in cardiac contractile behavior. Pereira et al. 2013 (13) showed 
unaltered basal cardiac function and Ca2+ handling in KO mice of either Epac1 or Epac2 and 
double KO mice. Moreover Epac2 and not Epac1, was shown to be essential for 8-CPT-
induced RyR2 activation, enhanced Ca2+ leak and decreased Ca2+ transient (13). However, 
Okumura et al. 2014 (14) found that loss of Epac1 decreased basal cardiac contractility, 
reduced Ca2+ transient and diminished SR Ca2+ storage. Overall, the effects of Epac in 
intracellular Ca2+ handling and contractility remain controversial. The apparent discrepancy 
may depend on experimental conditions. For instance, genetic background in the KO 
models, acute vs. chronic effects of 8-CPT, species and/or different extracellular Ca2+ 
([Ca2+]o) to which the myocytes are exposed. Related to the latter, it is important to consider 
that Ca2+ supply to the cell alters intracellular Ca2+, dynamically adjusting the balance 
between SR Ca2+ uptake and leak.
The aim of the present study was to elucidate if the acute effects of Epac stimulation depend 
on the SR Ca2+ handling state. In determining this, we varied [Ca2+]o in order to shift the SR 
balance from net Ca2+ accumulation to net Ca2+ release and we focused on the relevance of 
CaMKII-dependent phosphorylation of PLN and RyR2 in the response to Epac stimulation, 
through the use of transgenic mice with non-phosphorylatable CaMKII sites.
MATERIALS AND METHODS
2.1 Animals
The experiments were performed in male Wistar rats (200–300 g body weight), mice (25–30 
g) with genetic ablation of the CaMKII phosphorylatable site on RyR2 (RyR2-S2814A 
knock-in) (15) and mice expressing a mutant PLN in which both phosphorylatable residues 
(Ser16 and Thr17) were replaced by Ala (PLN-DM) (MMRRC, University of Missouri/
Harlam, Mouse Regional Resource Center, NCRR, NIH) (16). Transgenic mice were 
backcrossed to the C57BL/6 for over 10 generations. Age-matched wild type C57BL/6 mice 
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(WT) served as controls. Animals were maintained in accordance with the Institutional 
Animal Care and Use Committee (IACUC) of the School of Medicine, National University 
of La Plata, Argentina (Nro T05022014) conforming to the Guide for the Care and Use of 
Laboratory Animals (NIH, 2011).
2.2 Myocyte isolation
Myocytes were isolated by enzymatic digestion as previously described (17). Briefly, after 
reached phase III anesthesia verified by the loss of pedal withdrawal reflex (intraperitoneal 
injection of Ketamine/Diazepam (70mg/kg/5mg/kg for rat and 100mg/kg5mg/kg for mice) 
central thoracotomy were performed. The hearts were anticoagulated with heparin (2.5 
units/g body weight) excised and mounted in a Langendorff apparatus. They were then 
retrogradly perfused at 37 °C at a constant perfusion pressure of 80–90 mmHg with Hepes 
Buffer Solution (HBS) of the following composition (mM): 146.2 NaCl, 4.7 KCl, 1.0 CaCl2, 
10.0 Hepes, 0.35 NaH2PO4, 1.05 MgSO4, 10.0 glucose (pH adjusted to 7.4 with NaOH). 
The solution was continuously bubbled with 100% O2. After stabilization period of 4 min, 
the perfusion was switched to a nominally Ca2+-free HBS solution for 6 min. Hearts were 
then recirculated with collagenase (118 U ml−1) 0.1 mg ml−1 pronase and 1% bovine serum 
albumin (BSA), in HBS containing 50 μM CaCl2. Perfusion continued until the hearts 
became flaccid (15–25 min). They were then removed from the perfusion apparatus by 
cutting at the atria-ventricular junction. The desegregated myocytes were separated from the 
undigested tissue and rinsed several times with a HBS solution containing 1 % BSA and 500 
μM CaCl2. Ventricular myocytes were dispersed mechanically and filtered through a nylon 
mesh and allowed to sediment for 10 min. The sedimentation is repeated three times every 
10 min, while [Ca2+] (mM) was increased stepwise, from 0.125 to 0.25 through 1 mM 
[Ca2+]o (rat) or 1.8 (mice). Only rod-shaped myocytes with clear and distinct striations and 
an obvious marked shortening and relaxation on stimulation were used.
2.3 Myocyte shortening and [Ca2+]i measurements
Isolated myocytes were loaded with Fura-2/AM (2 μmol/L for 15 min). Residual 
extracellular dye was removed by centrifugation and the pellet was washed three times. 
[Ca2+]i was measured with an epi-fluorescence system (Ion Optix, Milton, MA, USA). 
Briefly, dye-loaded cells were placed in a chamber on the stage of an inverted microscope 
(Nikon.TE 2000-U) and continuously superfused with a HBS at a constant flow of 1 ml/min. 
Experiments were performed at room temperature (20–22°C) and myocytes were stimulated 
via two-platinum electrodes on either side of the bath at 1 Hz. The ratio of the Fura-2 
fluorescence (510 nm) obtained after exciting the dye at 340 and 380 nm was taken as an 
index of [Ca2+]i. Resting sarcomere length and cell shortening were measured by a video-
based motion detector (Crescent electronics, UT, USA). Myocytes were equilibrated in HBS 
at different [Ca2+]o and measurements were performed before and after the addition of 8-(4-
Chlorophenylthio)-2′-O-methyladenosine-3′, 5′-cyclic monophosphate (8-CPT, 10 μM) 
(Biolog). Different [Ca2+]o were selected from experiments in which the influence of 
[Ca2+]o on 8-CPT response was evaluated. For rat myocytes, 0.5 mM, 1 mM and 1.8 mM 
[Ca2+]o were chosen because at these concentrations 8-CPT showed a positive, unchanged 
or negative inotropic effect respectively. For mice myocytes, 1.8 mM and 2.5 mM [Ca2+]o 
were the concentrations at which 8-CPT showed a positive and no change in the inotropic 
Lezcano et al. Page 4









response respectively. Fluorescence and cell shortening data were stored for off-line analysis 
(ION WIZARD fluorescence analysis software). Ca2+ transients were analyzed as the mean 
value over a 10–12 records for each cell. SR Ca2+ content was determined by rapidly 
switching from the HBS to one of the same pH, containing 25 mM caffeine to cause SR 
Ca2+ release. Myocytes showing two or more spontaneous non-stimulated contractions and 
Ca2+ transients were considered arrhythmic.
2.4 Ca2+ sparks measurement
Rat ventricular myocytes were loaded with 10 μM Fluo-4-AM (Invitrogen) in HBS 
containing 1.0 mM [Ca2+]o for 20 min at room temperature, and mounted in a small 
chamber placed into an inverted microscope equipped with a 63× objective as previously 
described (18). After stabilization (usually 3–5 min), confocal line-scanning (512 × 512 
pixels and 4.3 ms per line) was performed along the longitudinal axis of cells (avoiding 
nuclei), using the Zeiss LSM 210 confocal system in quiescent cells. The Fluo-4 loaded 
myocytes were excited using the 488 nm argon laser and the fluorescence emission was 
recorded at 500–550 nm. Ca2+ sparks were measured using the ‘Sparkmaster’ plugin for 
ImageJ. A Ca2+ wave was defined as a continuous wave front in the line scan image 
visualized as a robust fluorescent line that propagates across the full width of the myocyte 
without breaking.
2.5 Electrophoresis and Western blot analysis
To determine the phosphorylation state of different proteins in response to Epac stimulation, 
rat isolated myocytes were plated on 35-mm tissue culture dishes, stimulated at 1 Hz and 
treated with or without 10 μM 8-CPT (Biolog) for 5–10 min in HBS containing 0.5; 1 and 
1.8 mM [Ca2+]o. When PKC inhibitor (calphostine C) was used, it was pre-incubated for 20 
min before the addition of 8-CPT. Treatment was stopped by immersing the dishes in liquid 
nitrogen. Cells were scraped off and centrifuged at 8000xg for 5 min. The pellet was re-
suspended in lysis buffer containing (in mM): 20 β-glycerophosphate, 50 NaF, 1 Na4P2O7; 2 
Na3VO4; 2 EGTA; 2 EDTA; 1 μM okadaic acid; 1% Triton X-100, 1% SDS and complete 
protease inhibitor cocktail (Roche). After protein measurement by Bradford’s method, 
samples were resolved in SDS-PAGE on either 6% gels (for RyR2) or 12% (w/v) gels (for 
the rest of the proteins), transferred to PVDF membranes and probed with antibodies raised 
against: Thr286-phosphorylated CaMKII (Abcam), Thr17-phosphorylated PLN (Badrilla), 
Ser16-phosphorylated PLN (Badrilla), total PLN (Abcam), Ser2814-phosphorylated RyR2 
(Badrilla), Ser2808-phosphorylated RyR2 (Badrilla), total RyR2 (Thermo Scientific), 
Ser282-phosphorylated MyBP-C (Enzo Life Sciences) and MyBP-C (Santa Cruz 
Biotechnology) and GAPDH (Millipore) generally overnight. Membranes were then 
incubated with the appropriate horseradish peroxidase-conjugated secondary antibody 
(Santa Cruz Biotechnology) and developed using an enhanced chemiluminescence reagent 
(Millipore). The signals emitted were detected using Chemidoc Imaging System (Bio-Rad) 
and analyzed with ImageJ software (NIH, Bethesda, MD, USA). The results were expressed 
by normalizing the densitometry signal obtained by GAPDH, PLN or RyR2 as 
corresponding.
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Data are express as mean± SEM. Unpaired, paired Student t-test or ANOVA followed by 
The Newman-Keuls test were used for statistical comparisons when appropriate. The 
incidence of arrhythmias was analyzed using Fisher’s exact probability test. Differences 
were considered significant at p<0.05.
RESULTS
Epac effects on contractility and intracellular Ca2+ handling depend on Ca2+ supply to the 
myocyte
To find an explanation for the contradictory results regarding the effects of Epac activation 
on contractility and intracellular Ca2+ homeostasis, we simultaneously measured cell 
shortening and intracellular Ca2+ transient in rat cardiomyocytes stimulated with the Epac 
selective activator, 8-CPT, at different [Ca2+]o. At 0.5 mM [Ca2+]o, 8-CPT elicited an 
increase in fractional sarcomere shortening and in steady-state twitch Ca2+ transient 
amplitude (Figure 1A–C). This positive inotropic effect was not observed at 1 mM [Ca2+]o 
and turned into a negative inotropic effect when [Ca2+]o was increased to 1.8 mM. 
Furthermore, only at low [Ca2+]o, exposure to 8-CPT produced a relaxant effect, evidenced 
by an acceleration of Ca2+ transient decay and myocyte relengthening (Figure 1D and E). 
The study of the kinetics of the sarcomere shortening and Tau for Ca2+ transient support the 
Epac-induced inotropic and relaxant effects observed at the different [Ca2+]o (Figure 1S A 
and B). In an attempt to examine 8-CPT-induced changes in myofilament Ca2+ sensitivity 
we plotted a phase-plane loop of sarcomere length vs. Ca2+ transient before and after 8-CPT 
treatment. At each [Ca2+]o explored, the relaxation phases in the absence and the presence of 
8-CPT were superimposed suggesting no changes in the apparent myofilament Ca2+ 
sensitivity (Figure 2S).
To determine if the effects of 8-CPT on contractility and Ca2+ transient were associated to 
changes in SR Ca2+ load, we measured caffeine-induced Ca2+ transients (Figure 2A and B). 
The results showed increase, no change and decrease in SR Ca2+ content at 0.5; 1 and 1.8 
mM [Ca2+]o respectively. Thus, 8-CPT-induced modifications in SR Ca2+ load could 
account for the inotropic changes produced by the Epac activator. Additionally, 8-CPT did 
not modify the decay time of the caffeine-evoked Ca2+ transient at any of the [Ca2+]o 
studied, indicating that Epac stimulation did not alter the activity of the Na+-Ca2+ exchanger 
(NCX) (Table S1).
To evaluate the effect of 8-CPT on spontaneous SR Ca2+ release events at the different 
[Ca2+]o, imaging studies were performed. Representative line-scan recordings (Figure 2C) 
and bar graphs containing summary data (Figure 2D) showed that 8-CPT enhanced the 
frequency of Ca2+ sparks at all [Ca2+]o studied with amplitude, duration and width of the 
Ca2+ sparks similar among groups (Table 2S). This spontaneous SR Ca2+ release was 
associated to enhanced diastolic Ca2+ at 1 and 1.8 mM [Ca2+]o (Figure 1S C). Moreover, at 
1.8 mM [Ca2+]o the Epac agonist initiated self-propagating Ca2+ waves which are the result 
of a substantial SR Ca2+ leak. Given that Ca2+ spark frequency is highly dependent on SR 
Ca2+ content, we compared the data obtained in Figures 2B and 2D. Only at 0.5 mM 
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[Ca2+]o, the increased in Ca2+ sparks induced by 8-CPT could be attributed to an increase in 
SR Ca2+ load. At 1 and 1.8 mM [Ca2+]o, there was no relationship between spontaneous SR 
Ca2+ release events and SR Ca2+ content. In fact, at 1.8 mM [Ca2+]o, the Epac agonist 
maximally increased Ca2+ spark frequency, despite a significantly diminished SR Ca2+ 
content. These apparently contradictory results could be explained by alterations at the level 
of RyR2, which can lead to abnormal SR Ca2+ spontaneous release independently on its 
Ca2+ content.
Taken together, the present results demonstrated that the myocyte response to 8-CPT 
depends on [Ca2+]o and suggest that the shift in the balance between SR Ca2+ uptake and 
leak at the different [Ca2+]o, determines the outcome of the contractile behavior due to Epac 
activation.
Epac-induced CaMKII-dependent PLN and RyR2 phosphorylation at different [Ca2+]o
It has been previously shown that Epac controls CaMKII activity, in a PKA-independent 
manner, and enhances CaMKII target phosphorylation of Thr17 of PLN and Ser2814 of 
RyR2. Phosphorylation of these two SR substrates is known to increase SR Ca2+ uptake and 
leak respectively. In order to investigate if PKC is responsible for CaMKII activation during 
Epac stimulation we performed experiments in the absence and presence of the PKC 
inhibitor, calphostin C (CC). Immunoblots and overall results of Figure 3A and B confirmed 
that 8-CPT increased the phosphorylation of CaMKII at Thr286 (autophosphorylation), PLN 
at Thr17 and RyR2 at Ser2814. These increases were completely prevented by the 
application of CC, indicating that PKC was upstream of CaMKII in the Epac-stimulated 
signaling pathway in our experimental conditions.
The Epac activator failed to increase the phosphorylation of MyBPC, a phosphoprotein 
known to regulate myofilament Ca2+ sensitivity (Figure 3C). Moreover, 8-CPT did not 
increase the phosphorylation of Ser16 of PLN and Ser2808 of RyR2, two PKA 
phosphorylatable sites, confirming the selectivity of the drug for Epac (Figure 3D and E).
To test whether differential CaMKII-dependent phosphorylations underlie different 
responses to Epac stimulation, we measured these phosphorylations in the absence and 
presence of 8-CPT at the three [Ca2+]o used. In the absence of the drug, the increase in 
[Ca2+]o from 0.5 to 1 mM significantly enhanced the phosphorylation of CaMKII and PLN, 
without increasing the phosphorylation of RyR2 (Figure 3F–H). This could explain the net 
SR Ca2+ gain (Figure 2B) due to the PLN-induced increase in SR Ca2+ uptake. Switching 
the [Ca2+]o from 1 mM to 1.8 mM, further increased CaMKII and PLN phosphorylations 
and promoted the enhancement of RyR2 phosphorylation. This latter mechanism by 
facilitating SR Ca2+ leak may be counteracting the effects of PLN phosphorylation and 
precluding the increase in SR Ca2+ content (Figure 2B). At all [Ca2+]o studied, treatment of 
the cardiomyocytes with the Epac selective agonist increased CaMKII-dependent 
phosphorylations compared with control conditions in the absence of drug (Figure 3C–E).
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Relative contribution of CaMKII-dependent PLN and RyR2 phosphorylations to the effects 
of Epac activation
The findings presented in the previous section did not allow us to draw conclusions about 
the impact of CaMKII-dependent PLN (Thr17) and RyR2 (Ser2814) phosphorylations on 
the effects of Epac activation at different [Ca2+]o. To resolve this issue, we took advantage of 
transgenic mice models in which both sites were rendered non-phosphorylatable (PLN-DM 
and RyR2-S2814A). We first characterized the effects of Epac activation in wild type mouse 
myocytes, looking for experimental conditions (different [Ca2+]o) that provide a comparable 
basal contractile state to rat myocytes. When studying the impact of [Ca2+]o on 8-CPT 
contractile response in mouse cardiomyocytes, a shift to the right with respect to the rat was 
observed. At 1.8 mM [Ca2+]o, 8-CPT elicited an increase in cell shortening and Ca2+ 
transient amplitude and a decrease in the relaxation times (Figure 4A–D). At 2.5 mM 
[Ca2+]o, the Epac activator failed to produce the inotropic and lusitropic effects. This 
behavior, similar to that observed in rat, indicates that differences in the response to Epac 
stimulation are not species-dependent. The 8-CPT studied effects, which appeared soon after 
drug exposure (1 min), remained stable for more than 10 min at 1.8 mM [Ca2+]o but at 2.5 
mM [Ca2+]o, measurements of [Ca2+]i transient and cell shortening were necessarily 
performed during the first 5 min of treatment because after this period, the Epac activator 
produced an increase in diastolic Ca2+, a decrease in the initial resting length and promoted 
the appearance of arrhythmic events in all treated mouse myocytes (Figure 5A and C).
We next tested the effects of Epac activation in myocytes from PLN-DM and RyR2-S2814A 
mice. The results showed that 8-CPT failed to induce positive inotropic and lusitropic effects 
in PLN-DM myocytes at 1.8 mM [Ca2+]o (Figure 4A–D). On the other hand, at 2.5 mM 
[Ca2+]o, 8-CPT-induced increments in resting length and diastolic Ca2+ and the appearance 
of arrhythmias were completely abolished in RyR2-S2814A myocytes (Figure 5B and C). 
The inotropic response of these mice to Epac activation did not differ from that observed in 
the wild type mouse myocytes (Figure 3S).
Taken together these findings demonstrate that CaMKII-dependent PLN phosphorylation is 
a necessary step for the positive inotropic effect of 8-CPT at low [Ca2+]o and that CaMKII-
dependent RyR2 phosphorylation is responsible for the spontaneous Ca2+ leak and the 
consequent arrhythmogenesis at high [Ca2+]o, consistent with previous studies (6, 10, 13). 
The results would also indicate that at each experimental condition the resultant effect of 
Epac activation is dependent on the prevailing mechanism of SR Ca2+ handling, i.e. uptake 
or leak.
DISCUSSION
The discovery of Epac proteins expanded the range of cAMP effectors and many of the 
mechanisms believe to be PKA-mediated proved to be Epac-dependent. At the level of the 
myocardium, the currently understanding of the effects of Epac activation remains 
controversial. Inconsistent results have been reported regarding the impact of Epac on Ca2+ 
homeostasis, contractility, apoptosis, hypertrophy and fibrosis (1, 2). The present study was 
carried out in order to clarify some of these discrepancies. We particularly focused on the 
effects of Epac activation on cardiomyocyte contractility and SR Ca2+ handling.
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The results obtained reveal that: 1) The activation of Epac promotes different effects on Ca2+ 
handling and contractility in cardiac myocytes, which do not depend on the species but on 
the experimental conditions that alter the fine-tuning of the SR Ca2+ handling; 2) Epac 
stimulation regulates both the uptake and release of Ca2+ from the SR; 3) CaMKII is an 
essential element in the downstream cascade of the Epac signaling, which through PLN 
phosphorylation determines the positive inotropic effect of Epac at low [Ca2+]o and through 
RyR2 phosphorylation is responsible for the arrhythmogenic effects of Epac activation at 
high [Ca2+]o and 4) PKC is involved in the Epac-induced CaMKII activation.
Epac in Ca2+ handling and contractility
The present results showed that at low [Ca2+]o, the Epac-specific agonist, 8-CPT, produced 
positive inotropic and relaxant effects, both in rat and mouse myocytes. These effects were 
associated with an increased SR Ca2+ load suggesting an enhancement of the SR Ca2+ 
uptake through the SERCA2a/PLN complex. The increment of CaMKII-dependent PLN 
phosphorylation and the use of PLN-DM mice definitively confirmed that an increase in SR 
Ca2+ uptake was underlying the contractile changes induced by Epac. CaMKII-dependent 
RyR2 phosphorylation also occurred associated to an increase in the spontaneous SR Ca2+ 
release. However, this Ca2+ leak seems to affect neither the SR Ca2+ load nor the diastolic 
Ca2+. We believe that at low [Ca2+]o, the stimulation of the uptake through the 
SERCA2a/PLN complex prevails over the leak of Ca2+ through the RyR2. However, this 
mechanism has been underestimated when the effects of Epac on Ca2+ handling and 
contractility was studied. A different situation occurred when Epac activation was studied at 
higher [Ca2+]o. In this environment, no contractile changes or a negative inotropic effect was 
detected. The Epac selective agonist produced a massive increase in SR Ca2+ leak-visualized 
by the presence of Ca2+ waves-, the increment in diastolic Ca2+ and the appearance of 
arrhythmias. These events occurred at reduced SR Ca2+ content, indicating a hyperactive 
RyR2. As in low [Ca2+]o, 8-CPT treatment increased both CaMKII-dependent RyR2 and 
PLN phosphorylation, however under this condition, RyR2 phosphorylation-mediated Ca2+ 
leak seemed to prevail over the PLN phosphorylation-mediated increase in SR Ca2+ uptake, 
leading to a loss in SR Ca2+ content. The lack of arrhythmic events in 8-CPT treated 
myocytes from RyR2-S2814A mice confirmed that CaMKII-dependent RyR2 
phosphorylation was responsible for the hyperactivity of the channel in this situation. Taken 
together, the present results indicate that Epac activation exacerbates the predominant 
mechanism of SR Ca2+ handling at each experimental condition (net Ca2+ accumulation vs. 
net Ca2+ release).
Taking this into consideration, the diverse effects of 8-CPT on intracellular Ca2+ 
homeostasis and contractility found by different authors could be comprehended. For 
instance, Oestreich et al. (5) using mouse myocytes at 2 mM [Ca2+]o, close to our 1.8 mM 
[Ca2+]o (low [Ca2+]o for the mice) reported an increased Ca2+ transient amplitude in 
response to Epac stimulation whereas Pereira et al. (6, 10) and Cazorla et al. (9) working 
with rat myocytes at 1.8 mM [Ca2+]o, situation of high [Ca2+]o in this species, found a 
reduced Ca2+ transient amplitude. In the acute stimulation of Epac, the participation of other 
non-SR proteins involved in the regulation of intracellular Ca2+ homeostasis such as the L-
type Ca2+ channel (6) or the NCX (6, 10 and the present work) seemed unlikely.
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Recently, the effect of Epac activation under different [Ca2+]o was studied in a rat 
multicellular ventricular preparation (19). Similarly to our results, Kaur et al. described a 
positive inotropic effect of Epac activation at low [Ca2+]o (0.5 mM) and a lack of effect 
when [Ca2+]o increased (1.5 mM). The authors attributed to a CaMKII-mediated 
enhancement in myofilament Ca2+ sensitivity the increase in contractility observed at 0.5 
mM [Ca2+]o. A previous evidence presented by Cazorla et al. (9) also supported an Epac-
induced sensitization of myofilament to Ca2+ in rat permeabilized cardiomyocytes. This 
effect was associated to a PKC and CaMKII-dependent increase in MyBPC and troponin-I 
phosphorylations. Notably, our present results are at odds with these previous studies. We 
were not able to detect changes in either apparent myofilament Ca2+ sensitivity or 
phosphorylation of MyBPC in response to 8-CPT. We cannot yet explain this negative result 
and certainly more experiments would be necessary to elucidate the role of Epac as regulator 
of myofilament function, which has been scarcely studied.
Arrhythmogenic effects of Epac
The arrhythmogenic effects of acute Epac stimulation were first reported by Hothi et al. 
(11). The fact that 8-CPT promoted ventricular arrhythmogenesis without changes in action 
potential duration, transmural repolarization gradient or ventricular refractoriness in isolated 
perfused mouse hearts and that the Epac agonist induced spontaneous Ca2+ transients and 
Ca2+ waves in isolated myocytes, led the authors to propose an aberrant SR Ca2+ release as 
the arrhythmogenic mechanism for Epac activation. This hypothesis was later supported by 
the finding of 8-CPT-induced enhancement of Ca2+ spark frequency and increase in 
CaMKII-dependent RyR2 phosphorylation, a posttranslational modification known to make 
the channel leaky (6–8, 10, 13). In this study, we were able to definitively establish that 
CaMKII-dependent RyR2 phosphorylation is an underlying mechanism of Epac-induced 
arrhythmogenesis by showing that 8-CPT failed to promote spontaneous Ca2+ transients and 
contractions in stimulated RyR2-S2814A mice myocytes. However, we still cannot discard 
the participation of other potentially arrhythmogenic targets also reported to be modulated 
by Epac (12, 20–23). Although in some of these studies, the effects of 8-CPT on L-type 
Ca2+ channel, slowed delayed-rectifier K+ current and transient receptor potential canonical 
(TRPC) channels were observed after sustained activation of Epac (12, 21, 23), in others, the 
effects were detected after acute stimulation of the cAMP effector (20, 22).
Epac-induced pathways of CaMKII stimulation
Our results showed that Epac activation increased CaMKII autophosphorylation and 
enhanced CaMKII phosphorylation of RyR2 and PLN in a PKC-dependent manner. These 
results are in line with those reported by Ostreicht et al. (9) and suggest that PKC and 
CaMKII share a common pathway. However, the precise interaction between the two kinases 
is still uncertain. One possibility is that PKC can directly activate CaMKII by 
phosphorylating the autophosphorylation site, as described in vitro (24). An alternative 
mechanism is a PKC indirect activation of CaMKII. In rat hippocampus (25, 26), PKC was 
shown to phosphorylate proteins that lead to: 1) increased intracellular Ca2+, 2) the release 
of bound calmodulin, making it available for CaMKII and 3) the redistribution of CaMKII, 
modifying its proximity to target proteins. Furthermore, a new signaling pathway involving 
PI3K/NOS has recently been reported to mediate Epac-induced CaMKII activation (8). The 
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evidence presented up to now, does not allow us to elucidate whether different CaMKII 
activation pathways during Epac stimulation work in parallel or constitute intermediaries of 
a single pathway.
Conclusion
Our study demonstrates that the effects of Epac activation are strongly conditioned by the 
steady-state Ca2+ levels at which the myocyte is functioning. As intracellular Ca2+ increases, 
the activity of CaMKII enhances and the phosphorylation of its SR substrates acquires 
different relevance in the control of SR Ca2+ handling. The Ca2+ uptake stimulated by the 
CaMKII-dependent PLN phosphorylation is gradually overcome by the Ca2+ leak facilitated 
by the CaMKII-dependent RyR2 phosphorylation. In this scenario, stimulation of Epac 
through the Epac/PKC/CaMKII exacerbates the prevailing mechanism. Therefore, under 
different physiological or pathological situations, this cAMP-induced signaling pathway 
may produce beneficial (increased contractility) or detrimental (impaired contractility and 
triggered arrhythmias) effects depending on the myocyte intracellular Ca2+ availability, 
dynamically regulated by the balance between SR Ca2+ uptake and leak.
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• Epac activation promotes different effects on Ca2+ handling and contractility 
in cardiac myocytes, which do not depend on the species but on the steady-
state Ca2+ levels at which the myocyte is functioning.
• Epac stimulation increased autophosphorylation of CaMKII and CaMKII-
dependent PLN and RyR2 phosphorylation at different [Ca2+]o studied.
• CaMKII-dependent PLN phosphorylation is crucial for determining the 
positive inotropic effect of Epac at low [Ca2+]o.
• CaMKII-dependent RyR2 phosphorylation is responsible for the 
arrhythmogenic effects of Epac activation at high [Ca2+]o.
• PKC is involved in the activation of CaMKII during Epac stimulation.
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Figure 1. Epac differentially modifies cell shortening, [Ca2+]i transient and relaxation at 
different [Ca2+]o
A, representative simultaneous recordings of cell shortening (above) and Ca2+ transient 
(below) in rat myocytes loaded with Fura-2AM and field-stimulated at 1 Hz, before (black 
traces) and after (red traces) 10 μM 8-CPT application at 0.5, 1 and 1.8 mM [Ca2+]o; B, C, 
D and E, overall results of sarcomere cell shortening; Ca2+ transient amplitude; time to 50 % 
relaxation (t1/2) of twitches and time to 50 % decay of Ca2+ transient (t1/2 Ca2+ transient) of 
rat myocytes before (white bars) and after (black bars) 10 μM 8-CPT. * p<0.05 paired t test 
vs. before 8-CPT stimulation at each [Ca2+]o. Numbers in bars indicate number of cells of at 
least 3 rats.
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Figure 2. Epac stimulation increases SR Ca2+ content and Ca2+ spark occurrence at different 
[Ca2+]o
A, typical records of caffeine-triggered Ca2+ transients and B, averaged amplitude of these 
transients of rat myocytes loaded with Fura-2AM in the absence and presence of 10 μM 8-
CPT. C, representative line-scan images of spontaneous Ca2+ sparks of myocytes loaded 
with Fluo-4 before (Control, left) and after treatment with 10 μM 8-CPT (right) at 0.5; 1 and 
1.8 mM [Ca2+]o. D, bar graph showing the measured Ca2+ spark frequency in control cells 
(white bars) and cells in the presence of 8-CPT (black bars) at different [Ca2+]o. Numbers in 
bars indicate number of cells from at least 3 rats. * p<0.05 vs. control at each [Ca2+]o. # 
p<0.05 vs. 1 mM [Ca2+]o in the absence of drug.
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Figure 3. Epac stimulation increases CaMKII-dependent phosphorylation of its substrates via 
PKC at different [Ca2+]o
Typical immunoblots (A) and overall results (B) of the autophosphorylation of CaMKII 
(Thr286 site) and site-specific CaMKII phosphorylation of PLN (Thr17) and RyR2 
(Ser2814) in rat myocytes incubated in the absence (white bars) or presence of 10 μM 8-
CPT (black bars) or in the simultaneous presence of 8-CPT and the PKC inhibitor, 0.5 μM 
calphostine C (CC, grey bars). * p<0.05 vs. control, in the absence of drug; † p<0.05 vs. 8-
CPT. C, D and E, typical immunoblots and overall results of the phosphorylation of myosin 
binding protein C (MyBP-C, Ser282) and the site-specific PKA phosphorylation of PLN 
(Ser16) and RyR2 (Ser2808), respectively. Cardiac myocytes incubated with 1 μM 
Isoproterenol (Iso) were used as positive controls. Experiments in A-E were performed at 1 
mM [Ca2+]o. F, G and H, CaMKII phosphorylation of the kinase, PLN and RyR2 at 
different [Ca2+]o. Numbers in bars indicate number of cells from at least 5 rats. * p<0.05 vs. 
control at each [Ca2+]o. # p<0.05 vs. 1 mM [Ca2+]o in the absence of drug. Ctrl, Control.
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Figure 4. Epac-induced positive inotropic and lusitropic effects are blunted in PLN-DM 
transgenic mice
A, sarcomere cell shortening; B, Ca2+ transient amplitude; C, time to 50 % relaxation (half 
relaxation time; t1/2) of twitches and D, time to 50 % decay of calcium transient of WT and 
PLN-DM mouse myocytes loaded with Fura-2AM and field-stimulated at 1 Hz, before 
(white bars) and during (black bars) 10 μM 8-CPT application at different [Ca2+]o. * p<0.05 
paired t test vs. before 8-CPT stimulation at each [Ca2+]o. Numbers in bars indicate number 
of cells of at least 5 mice.
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Figure 5. Epac-induced arrhythmogenesis is prevented in RyR2S2814A transgenic mice
Representative recordings of Ca2+ transient and sarcomere cell shortening of myocytes from 
WT mice (A) and RyR2-S2814A mice (B) before and after 5 min of application of 10 μM 8-
CPT at 2.5 mM [Ca2+]o. C, percentage of myocytes in each group that experienced 
arrhythmic episodes. Numbers in bars indicate number of cells of at least 5 mice per group. 
* p<0.05 vs. control by Fisher’s exact test for each mice.
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